Activities of Christa KLASS related to 2012/2066(INI)
Plenary speeches (1)
Protection of public health from endocrine disrupters (debate)
Shadow reports (1)
REPORT on the protection of public health from endocrine disrupters PDF (191 KB) DOC (126 KB)
Amendments (17)
Amendment 5 #
Motion for a resolution
Citation 4 b (new)
Citation 4 b (new)
– having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market,
Amendment 6 #
Motion for a resolution
Citation 4 a (new)
Citation 4 a (new)
– having regard to Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products,
Amendment 7 #
Motion for a resolution
Citation 5 a (new)
Citation 5 a (new)
- having regard to the OECD conceptual framework for testing and assessment of endocrine disruptors.
Amendment 8 #
Motion for a resolution
Citation 5 b (new)
Citation 5 b (new)
- having regard to the draft guidance document on standardised test guidelines for evaluating chemicals for endocrine disruptions (2011).
Amendment 9 #
Motion for a resolution
Citation 5 c (new)
Citation 5 c (new)
- having regard to the draft detailed review paper: state of the sciences on novel in vitro and in vivo screening and testing methods and endpoints for evaluating endocrine disruptors.
Amendment 19 #
Motion for a resolution
Recital B
Recital B
B. whereas there are many possible causes for a growing frequency of hormone- related disorders in humans; whereas there is now significant scientific evidence that this is partly due to the impact of chemicalsubstances with endocrine-disrupting properties;
Amendment 21 #
Motion for a resolution
Recital D – introductory part
Recital D – introductory part
D. whereas, in the case of chemicalsubstances with endocrine-disrupting properties, the difficulties of proving a causal link are exacerbated by a number of factors, such as that:
Amendment 28 #
Motion for a resolution
Recital D – indent 5 a (new)
Recital D – indent 5 a (new)
– lifestyle and personal habits, as reflected in, for example, stress, exercise, and diet, also affect the endocrine system;
Amendment 52 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Takes the view that the feared effectonce reliable indications of endocrine -disruptors are so serious thating effects have been produced, then, even in the absence of precise knowledge, including exact knowledge of causal links, should not prevent us from taking measures to protect humans and animals should be taken;
Amendment 61 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Calls, therefore, on the Commission to submit as soon as possible proposals for overarching criteria together with testing and information requirements for chemicals on the commercial market, and for EU legislation to make clear what is regarded as a substance with endocrine- disrupting properties; advocates considering the introduction of ‘maintains that the introduction of regulatory classes for endocrine -disruptor’ as a regulatory hazard classing substances should be considered;
Amendment 67 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Stresses that it is important for the criteria for endocrine-disrupting chemicalsubstances to be based on a comprehensive hazardrisk assessment;
Amendment 72 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Takes the view that the criteria for defining endocrine disruptors should be based on criteria for defining ‘adverse effect’ and ‘endocrine mode of action’, the WHO definition being an appropriate basis for that purpose; considers that both these criteria must be weighed up in parallel in order to carry out a comprehensive assessment; considers that proven effects should be assumed to be harmful as long as there isare no scientific data to indicate the opposite; stresses that any possible combination effects should be taken into consideration;
Amendment 79 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Stresses that the criteria determining what constitutes an endocrine disruptor should be scientifically based and that the precautionary principle should be applied, taking into account in particular the potency of substances, in order to identify those substances which produce strong damaging effects at low concentrations; considers that a socio-economic assessment should then be carried out in accordance with the relevant legislation;
Amendment 97 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Considers that it should be possible for decision-making bodies to deal with substances having similar chemical structurthe same modes of action and properties on a group basis if the manufacturer or importer cannot demonstrate that the chemical is safe in spite of its structural similarity, with a viewthe similarity in terms of its mode of action, or if no risk assessment can be produced to show that the chemical is safe to use, the object being to providinge the public as quickly as possible with protection from exposure to endocrine disruptors and to restricting the number of experiments on animals;
Amendment 124 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Takes the view that endocrine disruptors identified in accordance with Article 57(f) of Regulation (EC) No 1907/2006 should be regarded as Substances of Very High Concern within the meaning of the Reach Regulation; considers, therefore, that endocrine disruptors should be that the approach used to deal with endocrine disruptors, taking risk assessment into account, should therefore seek to make these substances subject to an authorisation requirement or restriction with a view to substitution;
Amendment 133 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Stresses that endocrine disruptors should be regarded as substances for which it is not possible to set a limit value at which effects may occur (‘non-threshold’ substances) and that, but that the values in question can in some cases be very low and any exposure to such substances above the limit value may entail a risk;
Amendment 145 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Calls on the Commission to include all relevant stakeholders in cooperation seeking to adopt the necessary legislative changes to improve protection of human health from hormone-disrupting chemicalsubstances;